Insights: Publications Costly Deals – New FTC rules on patent licenses in M&As have caused a storm. Two experts discuss why they could be bad for the pharma business

IPPro Life Sciences

close
Loading...
If you would like to receive related insights and information from Kilpatrick Townsend, please provide your contact details by filling out the form and clicking “Agree.” If you would like to access the PDF only, please click “Download Only.”